Image-guided nanomedicine for cancer

被引：20
作者：
Choi J.H. [1 ]
Lee Y.J. [2 ]
Kim D. [1 ]
机构：
[1] Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, Reynolds Medical Building, Suite 159, Mail Stop 1114, College Station, 77843-1114, TX
[2] Nutrition and Food Science Department, Texas A&M University, 2476 TAMU, College Station, 77843-2476, TX
来源：
Journal of Pharmaceutical Investigation | 2017年 / 47卷 / 1期
关键词：
Cancer; Inorganic nanoparticles; Organic nanoparticles; Theranostic;
D O I：
10.1007/s40005-016-0297-1
中图分类号：
学科分类号：
摘要：
Since current treatment options applicable to cancers are still confined to chemotherapeutics followed by surgical debulking, cancer disease is a second leading cause of death because of chemotherapeutics of non-specific biodistribution. Image-guided drug delivery system (IGDDS) is a real-time noninvasive imaging assessment of therapeutic response that has the strong potential to control or suppress cancer because imaging property offer the quantification of nanomedicine at the intended disease site, thus the potential assurance of adequate treatment and elimination of undesirable delay leading to poor clinical outcomes. Also, combining pH-sensitive advantages of nanoparticle with theranostic property will have high chance to overcome cancer. There have been intensive researches to develop innovative IGDDS by using nanoparticles including organic or inorganic theranostic (therapy + diagnostic) systems including liposomes, polymeric micelles, dendrimers, carbon nanotubes, gold nanoparticles, iron oxide nanoparticles, quantum dots, and silica nanoparticles. In this review, we will introduce various examples of each system and will discuss their theranostic applications. © 2016, The Korean Society of Pharmaceutical Sciences and Technology.
引用
收藏
页码：51 / 64
页数：13
相关论文
共 102 条
[1]  
Ahmed N., Fessi H., Elaissari A., Theranostic applications of nanoparticles in cancer, Drug Discov Today, 17, pp. 928-934, (2012)
[2]  
Akerman M.E., Chan W.C.W., Laakkonen P., Et al., Nanocrystal targeting in vivo, Proc Natl Acad Sci, 99, pp. 12617-12621, (2002)
[3]  
Alqawlaq S., Sivak J.M., Huzil J.T., Et al., Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy, Nanomed Nanotech Biol Med, 10, pp. 1637-1647, (2014)
[4]  
Benezra M., Penate-Medina O., Zanzonico P.B., Et al., Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma, J Clin Invest, 121, pp. 2768-2780, (2011)
[5]  
Berry C.C., Wells S., Charles S., Et al., Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro, Biomaterials, 24, pp. 4551-4557, (2003)
[6]  
Bosman A.W., Janssen H.M., Meijer E.W., About dendrimers: structure, physical properties, and applications, Chem Rev, 99, pp. 1665-1688, (1999)
[7]  
Braun G.B., Pallaoro A., Wu G., Et al., Laser-activated gene silencing via gold nanoshell–siRNA conjugates, ACS Nano, 3, pp. 2007-2015, (2009)
[8]  
Cai D., Mataraza J.M., Qin Z.-H., Et al., Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing, Nat Meth, 2, pp. 449-454, (2005)
[9]  
Chakravarty R., Goel S., Hong H., Et al., Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery, Nanomedicine, 10, pp. 1233-1246, (2015)
[10]  
Chen F., Hong H., Zhang Y., Et al., In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles, ACS Nano, 7, pp. 9027-9039, (2013)
12345678910